Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

Medicines and Healthcare products Regulatory Agency approves the use of the protein-based Novavax COVID-19 vaccine for use in adults over the age of 18 years

The Medicines and Healthcare products Regulatory Agency approves the use of the protein-based Novavax COVID-19 vaccine for use in adults over the age of 18 years.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthMedicines and Healthcare products Regulatory Agency approves the use of the protein-based Novavax COVID-19 vaccine for use in adults over the age of 18 years

The Medicines and Healthcare products Regulatory Agency approves the use of the protein-based Novavax COVID-19 vaccine for use in adults over the age of 18 years.

View Premium plansBrowse free archive reports